Severely impaired renal function
Also known as: Or Severe Renal Impairment / Severe Renal Impairment
Drug | Drug Name | Drug Description |
---|---|---|
DB12688 | Moxetumomab pasudotox | A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB12688 | Moxetumomab pasudotox | B-cell receptor CD22 | target |
DB12688 | Moxetumomab pasudotox | Elongation factor 2 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15059 | Aprocitentan | 1 | Completed | 1 |
DB13004 | Mavoglurant | 1 | Completed | 1 |
DB00243 | Ranolazine | 1 | Terminated | 1 |
DB09183 | Dasabuvir | 3 | Completed | 1 |
DB09296 | Ombitasvir | 3 | Completed | 1 |
DB09297 | Paritaprevir | 3 | Completed | 1 |
DB00811 | Ribavirin | 3 | Completed | 1 |
DB00503 | Ritonavir | 3 | Completed | 1 |
DB08860 | Pitavastatin | 4 | Completed | 1 |